For Residents

'Silent Hypoxemia' and Other Curious Clinical Observations in COVID-19

Author and Disclosure Information

Gary S. Ferenchick, MD, MS, a professor of medicine at Michigan State University, interviewed his daughter, Hannah R.B. Ferenchick, MD, an emergency and critical care physician working on the frontline in a busy Detroit hospital, about some of the unusual clinical features of patients with suspected or confirmed COVID-19.


 

Vidyard Video

This transcript has been edited for clarity.

Gary S. Ferenchick, MD, MS: I'm Gary Ferenchick with Hannah Ferenchick, who has agreed to join us to talk about what's going on in Detroit, and also about PPE and decontamination processes. Why don't you introduce yourself?

Hannah R.B. Ferenchick, MD: I am Hannah Ferenchick. I'm an ER physician and medical intensivist. I split my time between the medical ICU and the emergency department at Detroit Medical Center.

Dr Gary Ferenchick: We were talking earlier about some of the not-well-described clinical scenarios that patients with definitive COVID might present with. One of these was the idea of "silent hypoxemia." Could you describe that?

Dr Hannah Ferenchick: Silent hypoxemia is being described in many of these COVID patients. That means the patient is very hypoxemic—they may have an oxygen saturation of about 85% on room air, but clinically they look very comfortable—they are not dyspneic or tachypneic and may not even verbalize a significant sense of shortness of breath. It's not every patient, but it has been interesting to see patients sitting there looking fairly normal, with a resting oxygen saturation much lower than you would expect for someone who doesn't have underlying pulmonary disease or other symptoms.

Dr Gary Ferenchick: What abnormalities are you seeing on standard or not-so-standard lab tests?

Dr Hannah Ferenchick: Some of the characteristic lab findings we are seeing are lymphopenia and elevated inflammatory markers (eg, CRP). A couple of other atypical findings seem to be specific for COVID—elevated LDH, ferritin, CPK, and procalcitonin levels. Some of the hematologic markers that we look at—the coagulation profile studies—are also abnormal, showing thrombocytopenia and elevated D-dimer levels.

That constellation of symptoms represents more of a clinical picture. A lot of times we have only a very high clinical suspicion, because in many parts of the country it still takes days to get back a confirmatory PCR test.

Much like we do for the flu, the confirmatory test is a nasopharyngeal swab that is run for COVID/coronavirus PCR. Unfortunately the sensitivity of that test is not great. Some studies have quoted 75%-80%, so even a negative PCR does not necessarily rule out the disease, especially if you have a high clinical suspicion. A clinical suspicion is based on the typical symptoms. Many patients, although not all, will have symptoms of lower respiratory tract infection.

Dr Gary Ferenchick: So the right clinical scenario with the right hematologic/biochemical findings dramatically raises the chance that the patient has COVID?

Dr Hannah Ferenchick: Yes, and one thing that we have all been astonished by is how terrible some of these x-rays can look. There are a lot of typical findings on x-ray. Some describe them as looking like pulmonary edema, but the patient has no history of heart failure. Peripheral consolidation and ground-glass opacities are classically described. If you saw one of these x-rays from a patient with bacterial pneumonia, you would expect that patient to be very ill-appearing. Sometimes we get x-rays on patients who are sitting there, maybe mildly symptomatic on room air, and we are astonished by how terrible their x-rays look.

Pages

Recommended Reading

Social distancing comes to the medicine wards
Journal of Clinical Outcomes Management
Learning about the curve
Journal of Clinical Outcomes Management
FDA approves emergency use of saliva test to detect COVID-19
Journal of Clinical Outcomes Management
COVID-19: When health care personnel become patients
Journal of Clinical Outcomes Management
Making something ordinary out of the extraordinary
Journal of Clinical Outcomes Management
COVID-19 PPE-related skin effects described in survey of Chinese doctors, nurses
Journal of Clinical Outcomes Management
Pandemic strains blood supply for COVID-19 and noninfected patients
Journal of Clinical Outcomes Management
COVID-19 cases highlight longstanding racial disparities in health care
Journal of Clinical Outcomes Management
Senate Dems call for nationwide COVID-19 testing strategy, more funding
Journal of Clinical Outcomes Management
Database will collect data on COVID-19 in patients with MS
Journal of Clinical Outcomes Management